SNOA | NASDAQ

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. (SNOA) | runway 16.0 months | financing risk moderate | market cap $5M. Daily snapshot of financials, capital pressure, and rece...

Company websiteLast updated Apr 29, 2026

Share price

$1.06

As of Apr 29, 2026

Market cap

$5M

Snapshot valuation

30D volume

285,982 shares

Rolling average daily volume

Runway

16.0 months

Estimated from precomputed burn and cash

Financing risk

N/A

Financing risk is present, but the current picture is not yet acute.

Snapshot summary

Runway: 16.0 months based on estimated burn.

Recent financing detected on Apr 16, 2026.

Financing signal: Financing risk is present, but the current picture is not yet acute.

Recent developments

Sonoma Pharmaceuticals, Inc. S-1 2026-04-17

S-1 filing submitted on 2026-04-17.

Apr 16, 2026, 8:00 PM

Sonoma Pharmaceuticals, Inc. 8-K 2026-04-09

8-K filed on 2026-04-09.

Apr 8, 2026, 8:00 PM

Sonoma Pharmaceuticals, Inc. 10-Q 2026-02-10

10-Q filed on 2026-02-10.

Feb 9, 2026, 7:00 PM

Sonoma Pharmaceuticals, Inc. 8-K 2026-01-28

8-K filed on 2026-01-28.

Jan 27, 2026, 7:00 PM

Sonoma Pharmaceuticals, Inc. 8-K 2026-01-12

8-K filed on 2026-01-12.

Jan 11, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures